HEADER HYDROLASE/RECEPTOR 03-NOV-08 2W2P TITLE PCSK9-DELTAC D374A MUTANT BOUND TO WT EGF-A OF LDLR COMPND MOL_ID: 1; COMPND 2 MOLECULE: PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: CATALYTIC DOMAIN, RESIDUES 153-451; COMPND 5 SYNONYM: PROPROTEIN CONVERTASE PC9, SUBTILISIN/KEXIN-LIKE PROTEASE COMPND 6 PC9, NEURAL APOPTOSIS-REGULATED CONVERTASE 1, NARC-1, PCSK9; COMPND 7 EC: 3.4.21.-; COMPND 8 ENGINEERED: YES; COMPND 9 MUTATION: YES; COMPND 10 MOL_ID: 2; COMPND 11 MOLECULE: LOW-DENSITY LIPOPROTEIN RECEPTOR; COMPND 12 CHAIN: E; COMPND 13 FRAGMENT: EGF-A DOMAIN, RESIDUES 314-393; COMPND 14 SYNONYM: LDL RECEPTOR; COMPND 15 ENGINEERED: YES; COMPND 16 MOL_ID: 3; COMPND 17 MOLECULE: PROPROTEIN CONVERTASE SUBTILISIN/KEXIN TYPE 9; COMPND 18 CHAIN: P; COMPND 19 FRAGMENT: PRODOMAIN, RESIDUES 53-152; COMPND 20 SYNONYM: PROPROTEIN CONVERTASE PC9, SUBTILISIN/KEXIN-LIKE PROTEASE COMPND 21 PC9, NEURAL APOPTOSIS-REGULATED CONVERTASE 1, NARC-1, PCSK9; COMPND 22 EC: 3.4.21.-; COMPND 23 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 6 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 7 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 8 EXPRESSION_SYSTEM_PLASMID: PETM-10; SOURCE 9 MOL_ID: 2; SOURCE 10 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 11 ORGANISM_COMMON: HUMAN; SOURCE 12 ORGANISM_TAXID: 9606; SOURCE 13 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 14 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 15 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 16 EXPRESSION_SYSTEM_PLASMID: PETM-11; SOURCE 17 MOL_ID: 3; SOURCE 18 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 19 ORGANISM_COMMON: HUMAN; SOURCE 20 ORGANISM_TAXID: 9606; SOURCE 21 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 22 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 23 EXPRESSION_SYSTEM_STRAIN: BL21(DE3); SOURCE 24 EXPRESSION_SYSTEM_PLASMID: PETM-10 KEYWDS HYDROLASE-RECEPTOR COMPLEX, PCSK9, LDLR, PROPROTEIN CONVERTASE, LOW- KEYWDS 2 DENSITY LIPOPROTEIN RECEPTOR, EGF, CARDIOVASCULAR DISEASE, FAMILIAL KEYWDS 3 HYPERCHOLESTEROLEMIA, LIPID METABOLISM, SERINE PROTEASE, HYDROLASE, KEYWDS 4 LIPID TRANSPORT, STEROID METABOLISM, RECEPTOR EXPDTA X-RAY DIFFRACTION AUTHOR M.J.BOTTOMLEY,A.CIRILLO,L.ORSATTI,L.RUGGERI,T.S.FISHER,J.C.SANTORO, AUTHOR 2 R.T.CUMMINGS,R.M.CUBBON,P.LO SURDO,A.CALZETTA,A.NOTO,J.BAYSAROWICH, AUTHOR 3 M.MATTU,F.TALAMO,R.DE FRANCESCO,C.P.SPARROW,A.SITLANI,A.CARFI REVDAT 6 13-DEC-23 2W2P 1 LINK REVDAT 5 13-JUL-11 2W2P 1 VERSN REVDAT 4 27-OCT-09 2W2P 1 REMARK REVDAT 3 13-JAN-09 2W2P 1 JRNL REVDAT 2 23-DEC-08 2W2P 1 VERSN JRNL REVDAT 1 18-NOV-08 2W2P 0 JRNL AUTH M.J.BOTTOMLEY,A.CIRILLO,L.ORSATTI,L.RUGGERI,T.S.FISHER, JRNL AUTH 2 J.C.SANTORO,R.T.CUMMINGS,R.M.CUBBON,P.LO SURDO,A.CALZETTA, JRNL AUTH 3 A.NOTO,J.BAYSAROWICH,M.MATTU,F.TALAMO,R.DE FRANCESCO, JRNL AUTH 4 C.P.SPARROW,A.SITLANI,A.CARFI JRNL TITL STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF THE WILD TYPE JRNL TITL 2 PCSK9/EGF-AB COMPLEX AND NATURAL FH MUTANTS. JRNL REF J.BIOL.CHEM. V. 284 1313 2009 JRNL REFN ISSN 0021-9258 JRNL PMID 19001363 JRNL DOI 10.1074/JBC.M808363200 REMARK 2 REMARK 2 RESOLUTION. 2.62 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC 5.2.0019 REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.62 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 40.00 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 98.5 REMARK 3 NUMBER OF REFLECTIONS : 21932 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.228 REMARK 3 R VALUE (WORKING SET) : 0.226 REMARK 3 FREE R VALUE : 0.270 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.100 REMARK 3 FREE R VALUE TEST SET COUNT : 1185 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.62 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.69 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1599 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : NULL REMARK 3 BIN R VALUE (WORKING SET) : 0.3290 REMARK 3 BIN FREE R VALUE SET COUNT : 87 REMARK 3 BIN FREE R VALUE : 0.3690 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 3127 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 1 REMARK 3 SOLVENT ATOMS : 31 REMARK 3 REMARK 3 B VALUES. REMARK 3 B VALUE TYPE : LIKELY RESIDUAL REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 28.96 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : 1.88000 REMARK 3 B22 (A**2) : 1.88000 REMARK 3 B33 (A**2) : -3.75000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.358 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.276 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.207 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 21.454 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.927 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.906 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 3233 ; 0.007 ; 0.022 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 4402 ; 1.148 ; 1.965 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 422 ; 5.268 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 139 ;33.933 ;23.669 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 525 ;17.182 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 25 ;18.120 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 509 ; 0.072 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2451 ; 0.003 ; 0.020 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): 1397 ; 0.193 ; 0.200 REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): 2169 ; 0.298 ; 0.200 REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): 107 ; 0.123 ; 0.200 REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): 23 ; 0.223 ; 0.200 REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): 4 ; 0.105 ; 0.200 REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 2120 ; 0.355 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 3335 ; 0.658 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1220 ; 0.817 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1061 ; 1.439 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 3 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 153 A 447 REMARK 3 ORIGIN FOR THE GROUP (A): 2.7275 -13.3795 -22.2383 REMARK 3 T TENSOR REMARK 3 T11: 0.1883 T22: 0.0510 REMARK 3 T33: 0.1018 T12: 0.0477 REMARK 3 T13: -0.0368 T23: -0.0043 REMARK 3 L TENSOR REMARK 3 L11: 1.9996 L22: 1.5746 REMARK 3 L33: 3.8988 L12: 0.2825 REMARK 3 L13: 1.2023 L23: -0.2393 REMARK 3 S TENSOR REMARK 3 S11: -0.1764 S12: -0.1619 S13: 0.0724 REMARK 3 S21: 0.0674 S22: 0.1077 S23: 0.0639 REMARK 3 S31: -0.2857 S32: -0.2833 S33: 0.0687 REMARK 3 REMARK 3 TLS GROUP : 2 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : E 285 E 332 REMARK 3 ORIGIN FOR THE GROUP (A): 13.5104 2.0479 -43.7901 REMARK 3 T TENSOR REMARK 3 T11: 0.3640 T22: -0.0114 REMARK 3 T33: 0.0714 T12: -0.1317 REMARK 3 T13: -0.0742 T23: -0.0200 REMARK 3 L TENSOR REMARK 3 L11: 2.9499 L22: 8.9619 REMARK 3 L33: 5.8660 L12: 0.1122 REMARK 3 L13: -0.0524 L23: -5.5374 REMARK 3 S TENSOR REMARK 3 S11: 0.0985 S12: -0.1128 S13: 0.0307 REMARK 3 S21: -0.3207 S22: -0.3149 S23: -0.5148 REMARK 3 S31: 0.1374 S32: 0.1929 S33: 0.2164 REMARK 3 REMARK 3 TLS GROUP : 3 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : P 60 P 152 REMARK 3 ORIGIN FOR THE GROUP (A): 16.1185 -27.3791 -0.5443 REMARK 3 T TENSOR REMARK 3 T11: 0.2134 T22: 0.1033 REMARK 3 T33: 0.1075 T12: 0.1072 REMARK 3 T13: -0.0083 T23: 0.0112 REMARK 3 L TENSOR REMARK 3 L11: 2.2097 L22: 2.0287 REMARK 3 L33: 5.1326 L12: -0.1966 REMARK 3 L13: 1.4005 L23: -1.6564 REMARK 3 S TENSOR REMARK 3 S11: -0.0152 S12: -0.3068 S13: -0.1463 REMARK 3 S21: 0.0092 S22: 0.0446 S23: 0.1136 REMARK 3 S31: -0.2003 S32: -0.3162 S33: -0.0294 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.20 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS. REMARK 4 REMARK 4 2W2P COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 03-NOV-08. REMARK 100 THE DEPOSITION ID IS D_1290037853. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 30-JUN-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 7.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : ESRF REMARK 200 BEAMLINE : ID14-2 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.933 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC CCD REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : SCALA REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 23184 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.620 REMARK 200 RESOLUTION RANGE LOW (A) : 40.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 3.500 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 98.9 REMARK 200 DATA REDUNDANCY : 4.900 REMARK 200 R MERGE (I) : 0.10000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 10.4000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.62 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.76 REMARK 200 COMPLETENESS FOR SHELL (%) : 99.7 REMARK 200 DATA REDUNDANCY IN SHELL : 4.60 REMARK 200 R MERGE FOR SHELL (I) : 0.67000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : 10.40 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2W2N REMARK 200 REMARK 200 REMARK: NONE REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 70.00 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 4.10 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M HEPES PH 7.5, 10% (W/V) PEG 8000 REMARK 280 AND 8% (V/V) ETHYLENE GLYCOL REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 43 21 2 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,-Y,Z+1/2 REMARK 290 3555 -Y+1/2,X+1/2,Z+3/4 REMARK 290 4555 Y+1/2,-X+1/2,Z+1/4 REMARK 290 5555 -X+1/2,Y+1/2,-Z+3/4 REMARK 290 6555 X+1/2,-Y+1/2,-Z+1/4 REMARK 290 7555 Y,X,-Z REMARK 290 8555 -Y,-X,-Z+1/2 REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 104.87250 REMARK 290 SMTRY1 3 0.000000 -1.000000 0.000000 42.05300 REMARK 290 SMTRY2 3 1.000000 0.000000 0.000000 42.05300 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 157.30875 REMARK 290 SMTRY1 4 0.000000 1.000000 0.000000 42.05300 REMARK 290 SMTRY2 4 -1.000000 0.000000 0.000000 42.05300 REMARK 290 SMTRY3 4 0.000000 0.000000 1.000000 52.43625 REMARK 290 SMTRY1 5 -1.000000 0.000000 0.000000 42.05300 REMARK 290 SMTRY2 5 0.000000 1.000000 0.000000 42.05300 REMARK 290 SMTRY3 5 0.000000 0.000000 -1.000000 157.30875 REMARK 290 SMTRY1 6 1.000000 0.000000 0.000000 42.05300 REMARK 290 SMTRY2 6 0.000000 -1.000000 0.000000 42.05300 REMARK 290 SMTRY3 6 0.000000 0.000000 -1.000000 52.43625 REMARK 290 SMTRY1 7 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY2 7 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 7 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 8 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY2 8 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY3 8 0.000000 0.000000 -1.000000 104.87250 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PQS REMARK 350 TOTAL BURIED SURFACE AREA: 4030 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 22370 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -28.6 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, E, P REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 400 REMARK 400 COMPOUND REMARK 400 ENGINEERED RESIDUE IN CHAIN A, ASP 374 TO ALA REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 TYR A 166 REMARK 465 ARG A 167 REMARK 465 ALA A 168 REMARK 465 ASP A 169 REMARK 465 GLU A 170 REMARK 465 TYR A 171 REMARK 465 GLN A 172 REMARK 465 PRO A 173 REMARK 465 PRO A 174 REMARK 465 ASP A 175 REMARK 465 GLY A 176 REMARK 465 GLY A 177 REMARK 465 SER A 178 REMARK 465 GLY A 213 REMARK 465 THR A 214 REMARK 465 ARG A 215 REMARK 465 PHE A 216 REMARK 465 HIS A 217 REMARK 465 ARG A 218 REMARK 465 GLN A 219 REMARK 465 ALA A 220 REMARK 465 THR A 448 REMARK 465 HIS A 449 REMARK 465 GLY A 450 REMARK 465 ALA A 451 REMARK 465 ALA A 452 REMARK 465 GLY A 453 REMARK 465 THR A 454 REMARK 465 ALA A 455 REMARK 465 ALA A 456 REMARK 465 ALA A 457 REMARK 465 SER A 458 REMARK 465 HIS A 459 REMARK 465 HIS A 460 REMARK 465 HIS A 461 REMARK 465 HIS A 462 REMARK 465 HIS A 463 REMARK 465 HIS A 464 REMARK 465 MET E 266 REMARK 465 LYS E 267 REMARK 465 HIS E 268 REMARK 465 HIS E 269 REMARK 465 HIS E 270 REMARK 465 HIS E 271 REMARK 465 HIS E 272 REMARK 465 HIS E 273 REMARK 465 PRO E 274 REMARK 465 MET E 275 REMARK 465 SER E 276 REMARK 465 ASP E 277 REMARK 465 TYR E 278 REMARK 465 ASP E 279 REMARK 465 ILE E 280 REMARK 465 PRO E 281 REMARK 465 THR E 282 REMARK 465 THR E 283 REMARK 465 GLU E 284 REMARK 465 ASP E 333 REMARK 465 ILE E 334 REMARK 465 ASP E 335 REMARK 465 GLU E 336 REMARK 465 CYS E 337 REMARK 465 GLN E 338 REMARK 465 ASP E 339 REMARK 465 PRO E 340 REMARK 465 ASP E 341 REMARK 465 THR E 342 REMARK 465 CYS E 343 REMARK 465 SER E 344 REMARK 465 GLN E 345 REMARK 465 LEU E 346 REMARK 465 CYS E 347 REMARK 465 VAL E 348 REMARK 465 ASN E 349 REMARK 465 LEU E 350 REMARK 465 GLU E 351 REMARK 465 GLY E 352 REMARK 465 GLY E 353 REMARK 465 TYR E 354 REMARK 465 LYS E 355 REMARK 465 CYS E 356 REMARK 465 GLN E 357 REMARK 465 CYS E 358 REMARK 465 GLU E 359 REMARK 465 GLU E 360 REMARK 465 GLY E 361 REMARK 465 PHE E 362 REMARK 465 GLN E 363 REMARK 465 LEU E 364 REMARK 465 ASP E 365 REMARK 465 PRO E 366 REMARK 465 HIS E 367 REMARK 465 THR E 368 REMARK 465 LYS E 369 REMARK 465 ALA E 370 REMARK 465 CYS E 371 REMARK 465 LYS E 372 REMARK 465 MET P 39 REMARK 465 LYS P 40 REMARK 465 GLY P 41 REMARK 465 SER P 42 REMARK 465 LYS P 43 REMARK 465 GLY P 44 REMARK 465 SER P 45 REMARK 465 LYS P 46 REMARK 465 GLY P 47 REMARK 465 SER P 48 REMARK 465 LYS P 49 REMARK 465 PRO P 50 REMARK 465 MET P 51 REMARK 465 SER P 52 REMARK 465 ALA P 53 REMARK 465 GLU P 54 REMARK 465 ALA P 55 REMARK 465 PRO P 56 REMARK 465 GLU P 57 REMARK 465 HIS P 58 REMARK 465 GLY P 59 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 ARG A 165 CG CD NE CZ NH1 NH2 REMARK 470 LEU A 179 CG CD1 CD2 REMARK 470 ASN E 285 CG OD1 ND2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 LEU P 133 CA - CB - CG ANGL. DEV. = 14.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 186 -150.58 -145.52 REMARK 500 ALA A 245 131.95 -30.94 REMARK 500 VAL A 280 -101.54 -123.04 REMARK 500 PRO A 288 55.61 -94.00 REMARK 500 ASN A 317 42.08 -102.52 REMARK 500 ARG A 319 48.02 38.42 REMARK 500 ASN A 340 -169.50 -102.37 REMARK 500 LEU A 351 -158.82 -118.75 REMARK 500 PHE E 288 -89.53 -114.34 REMARK 500 HIS E 306 -86.77 -121.43 REMARK 500 ARG E 329 -36.67 -136.33 REMARK 500 THR P 61 -164.97 -117.10 REMARK 500 HIS P 139 -12.71 76.21 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 CA E1333 CA REMARK 620 N RES CSSEQI ATOM REMARK 620 1 THR E 294 O REMARK 620 2 GLU E 296 OE1 67.0 REMARK 620 3 ASP E 310 OD2 78.3 86.4 REMARK 620 4 LEU E 311 O 144.5 147.9 94.4 REMARK 620 5 GLY E 314 O 141.9 75.9 108.6 73.4 REMARK 620 N 1 2 3 4 REMARK 700 REMARK 700 SHEET REMARK 700 THE SHEET STRUCTURE OF THIS MOLECULE IS BIFURCATED. IN REMARK 700 ORDER TO REPRESENT THIS FEATURE IN THE SHEET RECORDS BELOW, REMARK 700 TWO SHEETS ARE DEFINED. REMARK 800 REMARK 800 SITE REMARK 800 SITE_IDENTIFIER: AC1 REMARK 800 EVIDENCE_CODE: SOFTWARE REMARK 800 SITE_DESCRIPTION: BINDING SITE FOR RESIDUE CA E1333 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 1F5Y RELATED DB: PDB REMARK 900 NMR STRUCTURE OF A CONCATEMER OF THE FIRST AND SECOND LIGAND- REMARK 900 BINDING MODULES OF THE HUMAN LDL RECEPTOR REMARK 900 RELATED ID: 1HJ7 RELATED DB: PDB REMARK 900 NMR STUDY OF A PAIR OF LDL RECEPTOR CA ==2+== BINDING EPIDERMAL REMARK 900 GROWTH FACTOR-LIKE DOMAINS, 20 STRUCTURES REMARK 900 RELATED ID: 1N7D RELATED DB: PDB REMARK 900 EXTRACELLULAR DOMAIN OF THE LDL RECEPTOR REMARK 900 RELATED ID: 2FCW RELATED DB: PDB REMARK 900 STRUCTURE OF A COMPLEX BETWEEN THE PAIR OF THE LDL RECEPTORLIGAND- REMARK 900 BINDING MODULES 3-4 AND THE RECEPTOR ASSOCIATEDPROTEIN (RAP). REMARK 900 RELATED ID: 1I0U RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE AND BACKBONE DYNAMICS OF A CONCATEMER OFEGF- REMARK 900 HOMOLOGY MODULES OF THE HUMAN LOW DENSITY LIPOPROTEINRECEPTOR REMARK 900 RELATED ID: 1D2J RELATED DB: PDB REMARK 900 LDL RECEPTOR LIGAND-BINDING MODULE 6 REMARK 900 RELATED ID: 1LRX RELATED DB: PDB REMARK 900 THEORETIC MODEL OF THE HUMAN LOW-DENSITY LIPOPROTEINRECEPTOR YWTD REMARK 900 BETA-PROPELLER DOMAIN REMARK 900 RELATED ID: 1HZ8 RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE AND BACKBONE DYNAMICS OF A CONCATEMER OFEGF- REMARK 900 HOMOLOGY MODULES OF THE HUMAN LOW DENSITY LIPOPROTEINRECEPTOR REMARK 900 RELATED ID: 1F8Z RELATED DB: PDB REMARK 900 NMR STRUCTURE OF THE SIXTH LIGAND-BINDING MODULE OF THE LDLRECEPTOR REMARK 900 RELATED ID: 1XFE RELATED DB: PDB REMARK 900 SOLUTION STRUCTURE OF THE LA7-EGFA PAIR FROM THE LDLRECEPTOR REMARK 900 RELATED ID: 1AJJ RELATED DB: PDB REMARK 900 LDL RECEPTOR LIGAND-BINDING MODULE 5, CALCIUM-COORDINATING REMARK 900 RELATED ID: 1LDL RELATED DB: PDB REMARK 900 RELATED ID: 1LDR RELATED DB: PDB REMARK 900 SECOND REPEAT OF THE LDL RECEPTOR LIGAND- BINDING DOMAIN REMARK 900 RELATED ID: 1IJQ RELATED DB: PDB REMARK 900 CRYSTAL STRUCTURE OF THE LDL RECEPTOR YWTD- EGF DOMAIN PAIR REMARK 900 RELATED ID: 2W2O RELATED DB: PDB REMARK 900 PCSK9-DELTAC D374Y MUTANT BOUND TO WT EGF -A OF LDLR REMARK 900 RELATED ID: 2W2M RELATED DB: PDB REMARK 900 WT PCSK9-DELTAC BOUND TO WT EGF-A OF LDLR REMARK 900 RELATED ID: 2W2Q RELATED DB: PDB REMARK 900 PCSK9-DELTAC D374H MUTANT BOUND TO WT EGF -A OF LDLR REMARK 900 RELATED ID: 2W2N RELATED DB: PDB REMARK 900 WT PCSK9-DELTAC BOUND TO EGF-A H306Y MUTANT OF LDLR REMARK 999 REMARK 999 SEQUENCE REMARK 999 HUMAN PCSK9 CATALYTIC DOMAIN. THE LAST 13 RESIDUES IN THE REMARK 999 SEQUENCE ABOVE ARE A CLONING ARTEFACT, A LINKER AND A 6HIS REMARK 999 TAG. REMARK 999 HUMAN LDLR EGF-AB DOMAIN. THE FIRST 27 RESIDUES IN THE REMARK 999 SEQUENCE ABOVE ARE A CLONING ARTEFACT, A 6HIS TAG AND A REMARK 999 LINKER. REMARK 999 HUMAN PCSK9 PRODOMAIN. THE FIRST 14 RESIDUES IN THE REMARK 999 SEQUENCE ABOVE ARE A CLONING ARTEFACT. DBREF 2W2P P 39 52 PDB 2W2P 2W2P 39 52 DBREF 2W2P P 53 152 UNP Q8NBP7 PCSK9_HUMAN 53 152 DBREF 2W2P A 153 451 UNP Q8NBP7 PCSK9_HUMAN 153 451 DBREF 2W2P A 452 464 PDB 2W2P 2W2P 452 464 DBREF 2W2P E 266 292 PDB 2W2P 2W2P 266 292 DBREF 2W2P E 293 372 UNP P01130 LDLR_HUMAN 314 393 SEQADV 2W2P ALA A 374 UNP Q8NBP7 ASP 374 ENGINEERED MUTATION SEQRES 1 A 312 SER ILE PRO TRP ASN LEU GLU ARG ILE THR PRO PRO ARG SEQRES 2 A 312 TYR ARG ALA ASP GLU TYR GLN PRO PRO ASP GLY GLY SER SEQRES 3 A 312 LEU VAL GLU VAL TYR LEU LEU ASP THR SER ILE GLN SER SEQRES 4 A 312 ASP HIS ARG GLU ILE GLU GLY ARG VAL MET VAL THR ASP SEQRES 5 A 312 PHE GLU ASN VAL PRO GLU GLU ASP GLY THR ARG PHE HIS SEQRES 6 A 312 ARG GLN ALA SER LYS CYS ASP SER HIS GLY THR HIS LEU SEQRES 7 A 312 ALA GLY VAL VAL SER GLY ARG ASP ALA GLY VAL ALA LYS SEQRES 8 A 312 GLY ALA SER MET ARG SER LEU ARG VAL LEU ASN CYS GLN SEQRES 9 A 312 GLY LYS GLY THR VAL SER GLY THR LEU ILE GLY LEU GLU SEQRES 10 A 312 PHE ILE ARG LYS SER GLN LEU VAL GLN PRO VAL GLY PRO SEQRES 11 A 312 LEU VAL VAL LEU LEU PRO LEU ALA GLY GLY TYR SER ARG SEQRES 12 A 312 VAL LEU ASN ALA ALA CYS GLN ARG LEU ALA ARG ALA GLY SEQRES 13 A 312 VAL VAL LEU VAL THR ALA ALA GLY ASN PHE ARG ASP ASP SEQRES 14 A 312 ALA CYS LEU TYR SER PRO ALA SER ALA PRO GLU VAL ILE SEQRES 15 A 312 THR VAL GLY ALA THR ASN ALA GLN ASP GLN PRO VAL THR SEQRES 16 A 312 LEU GLY THR LEU GLY THR ASN PHE GLY ARG CYS VAL ASP SEQRES 17 A 312 LEU PHE ALA PRO GLY GLU ASP ILE ILE GLY ALA SER SER SEQRES 18 A 312 ALA CYS SER THR CYS PHE VAL SER GLN SER GLY THR SER SEQRES 19 A 312 GLN ALA ALA ALA HIS VAL ALA GLY ILE ALA ALA MET MET SEQRES 20 A 312 LEU SER ALA GLU PRO GLU LEU THR LEU ALA GLU LEU ARG SEQRES 21 A 312 GLN ARG LEU ILE HIS PHE SER ALA LYS ASP VAL ILE ASN SEQRES 22 A 312 GLU ALA TRP PHE PRO GLU ASP GLN ARG VAL LEU THR PRO SEQRES 23 A 312 ASN LEU VAL ALA ALA LEU PRO PRO SER THR HIS GLY ALA SEQRES 24 A 312 ALA GLY THR ALA ALA ALA SER HIS HIS HIS HIS HIS HIS SEQRES 1 E 107 MET LYS HIS HIS HIS HIS HIS HIS PRO MET SER ASP TYR SEQRES 2 E 107 ASP ILE PRO THR THR GLU ASN LEU TYR PHE GLN GLY ALA SEQRES 3 E 107 MET GLY THR ASN GLU CYS LEU ASP ASN ASN GLY GLY CYS SEQRES 4 E 107 SER HIS VAL CYS ASN ASP LEU LYS ILE GLY TYR GLU CYS SEQRES 5 E 107 LEU CYS PRO ASP GLY PHE GLN LEU VAL ALA GLN ARG ARG SEQRES 6 E 107 CYS GLU ASP ILE ASP GLU CYS GLN ASP PRO ASP THR CYS SEQRES 7 E 107 SER GLN LEU CYS VAL ASN LEU GLU GLY GLY TYR LYS CYS SEQRES 8 E 107 GLN CYS GLU GLU GLY PHE GLN LEU ASP PRO HIS THR LYS SEQRES 9 E 107 ALA CYS LYS SEQRES 1 P 114 MET LYS GLY SER LYS GLY SER LYS GLY SER LYS PRO MET SEQRES 2 P 114 SER ALA GLU ALA PRO GLU HIS GLY THR THR ALA THR PHE SEQRES 3 P 114 HIS ARG CYS ALA LYS ASP PRO TRP ARG LEU PRO GLY THR SEQRES 4 P 114 TYR VAL VAL VAL LEU LYS GLU GLU THR HIS LEU SER GLN SEQRES 5 P 114 SER GLU ARG THR ALA ARG ARG LEU GLN ALA GLN ALA ALA SEQRES 6 P 114 ARG ARG GLY TYR LEU THR LYS ILE LEU HIS VAL PHE HIS SEQRES 7 P 114 GLY LEU LEU PRO GLY PHE LEU VAL LYS MET SER GLY ASP SEQRES 8 P 114 LEU LEU GLU LEU ALA LEU LYS LEU PRO HIS VAL ASP TYR SEQRES 9 P 114 ILE GLU GLU ASP SER SER VAL PHE ALA GLN HET CA E1333 1 HETNAM CA CALCIUM ION FORMUL 4 CA CA 2+ FORMUL 5 HOH *31(H2 O) HELIX 1 1 PRO A 155 ILE A 161 1 7 HELIX 2 2 ASP A 224 GLY A 236 1 13 HELIX 3 3 VAL A 261 GLN A 278 1 18 HELIX 4 4 SER A 294 ALA A 307 1 14 HELIX 5 5 GLY A 384 GLU A 403 1 20 HELIX 6 6 THR A 407 SER A 419 1 13 HELIX 7 7 ASN A 425 PHE A 429 5 5 HELIX 8 8 PRO A 430 ARG A 434 5 5 HELIX 9 9 ASN E 295 ASP E 299 5 5 HELIX 10 10 ASP E 299 CYS E 304 5 6 HELIX 11 11 ALA E 327 ARG E 329 5 3 HELIX 12 12 LYS P 69 PRO P 71 5 3 HELIX 13 13 HIS P 87 ARG P 105 1 19 HELIX 14 14 SER P 127 ASP P 129 5 3 HELIX 15 15 LEU P 130 LYS P 136 1 7 SHEET 1 AA 7 VAL A 200 GLU A 206 0 SHEET 2 AA 7 SER A 246 ARG A 251 1 O MET A 247 N MET A 201 SHEET 3 AA 7 GLU A 181 ASP A 186 1 O VAL A 182 N ARG A 248 SHEET 4 AA 7 LEU A 283 LEU A 287 1 O VAL A 284 N TYR A 183 SHEET 5 AA 7 VAL A 310 ALA A 314 1 O VAL A 310 N VAL A 285 SHEET 6 AA 7 ILE A 334 THR A 339 1 O ILE A 334 N THR A 313 SHEET 7 AA 7 LEU A 361 PRO A 364 1 O LEU A 361 N GLY A 337 SHEET 1 AB 4 LYS A 258 THR A 260 0 SHEET 2 AB 4 VAL P 140 ALA P 151 -1 O VAL P 149 N GLY A 259 SHEET 3 AB 4 LEU A 289 GLY A 292 -1 O ALA A 290 N PHE P 150 SHEET 4 AB 4 TYR A 325 SER A 326 -1 O SER A 326 N GLY A 291 SHEET 1 AC 3 LYS A 258 THR A 260 0 SHEET 2 AC 3 VAL P 140 ALA P 151 -1 O VAL P 149 N GLY A 259 SHEET 3 AC 3 THR P 63 HIS P 65 1 O THR P 63 N ILE P 143 SHEET 1 AD 4 ILE A 368 SER A 372 0 SHEET 2 AD 4 CYS A 378 GLN A 382 -1 O CYS A 378 N SER A 372 SHEET 3 AD 4 VAL E 307 ASP E 310 -1 O CYS E 308 N PHE A 379 SHEET 4 AD 4 TYR E 315 LEU E 318 -1 O GLU E 316 N ASN E 309 SHEET 1 AE 2 ALA A 420 LYS A 421 0 SHEET 2 AE 2 LEU A 440 VAL A 441 -1 O VAL A 441 N ALA A 420 SHEET 1 EA 2 LEU E 325 VAL E 326 0 SHEET 2 EA 2 ARG E 330 CYS E 331 -1 O ARG E 330 N VAL E 326 SSBOND 1 CYS A 223 CYS A 255 1555 1555 2.05 SSBOND 2 CYS A 323 CYS A 358 1555 1555 2.06 SSBOND 3 CYS A 375 CYS A 378 1555 1555 2.04 SSBOND 4 CYS E 297 CYS E 308 1555 1555 2.04 SSBOND 5 CYS E 304 CYS E 317 1555 1555 2.04 SSBOND 6 CYS E 319 CYS E 331 1555 1555 2.05 LINK O THR E 294 CA CA E1333 1555 1555 2.46 LINK OE1 GLU E 296 CA CA E1333 1555 1555 2.54 LINK OD2 ASP E 310 CA CA E1333 1555 1555 2.37 LINK O LEU E 311 CA CA E1333 1555 1555 2.46 LINK O GLY E 314 CA CA E1333 1555 1555 2.43 CISPEP 1 SER A 326 PRO A 327 0 -1.76 CISPEP 2 ASN E 285 LEU E 286 0 2.30 CISPEP 3 THR P 60 THR P 61 0 0.01 SITE 1 AC1 5 THR E 294 GLU E 296 ASP E 310 LEU E 311 SITE 2 AC1 5 GLY E 314 CRYST1 84.106 84.106 209.745 90.00 90.00 90.00 P 43 21 2 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.011890 0.000000 0.000000 0.00000 SCALE2 0.000000 0.011890 0.000000 0.00000 SCALE3 0.000000 0.000000 0.004768 0.00000